Ali Shakerimoghaddam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Shakerimoghaddam has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Javad Behroozi
Cancer Epidemiology Research Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran
2 shared publicationsMahdi Ghorbani
Cancer Epidemiology Research Center (AJA-CERTC), AJA University of Medical Sciences, Tehran, Iran
2 shared publicationsMohsen Chamanara
Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran
2 shared publicationsReza Heidari
Infectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran
2 shared publications- Ailar Jamalli
Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
1 shared publication Ali Gholami
Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Mpox and Varicella Zoster Virus coinfection in endemic and outbreak settings: a systematic review and meta-analysis
Background: MPOX-VZV co-infection poses diagnostic challenges and public health implications due to the overlap in clinical presentation and complications. Evidence on the epidemiology and clinical outcomes of MPOX-VZV co-infection remains limited. This systematic review and meta-analysis summarize the available epidemiological evidence and discusses the associated diagnostic and public health implications. Methods: A systematic and comprehensive literature search was performed in PubMed, Scopus, Web of Science, EMBASE, Google Scholar, and the Cochrane Library for studies published between January 2000 and October 2024, following PRISMA guidelines. We included studies that reported MPOX–VZV coinfection prevalence. Standard methods were used for data extraction and meta-analysis, and methodological quality was assessed using the Appraisal tool for Cross-Sectional Studies (AXIS). The pooled prevalence was derived from a random-effects meta-analysis; heterogeneity was evaluated with Cochran’s Q and I² statistics. Sensitivity analysis and tests for small-study effects were also performed (Egger’s regression, Begg’s test, and funnel plots). Subgroup analyses by region of residence and study period were also performed using the random-effects model. Results: Of the 860 records identified, 12 studies were eligible for inclusion, with data from the Democratic Republic of Congo, Nigeria, Brazil, Central African Republic, and Pakistan. The pooled prevalence across the included study populations was 21.3% (95% CI: 15.0–29.4%, Z = 5.93, P < 0.001). There was substantial heterogeneity (I²=93.6%), and event rates varied by region, study design, and diagnostic approach. The sensitivity analyses showed event rates ranging from 17.8% to 27.2% (I²=93.6%). Egger’s and Begg’s tests were non-significant; however, with only 12 studies, publication bias could not be excluded. Subgroup analyses showed comparable pooled prevalence between endemic and non-endemic settings and between the pre-2022 and 2022-outbreak periods, with neither region of residence nor study period reaching statistical significance as a moderator of prevalence (Q-between p = 0.907 and p = 0.132, respectively). Conclusions: In the included study populations, MPOX–VZV coinfection was observed in approximately one in five patients with mpox, but this estimate should be interpreted cautiously because of substantial heterogeneity and limited geographic coverage. Improved differential diagnostics, integrated surveillance, clinician awareness, and targeted public health interventions are recommended, particularly in endemic settings. Future research should clarify the epidemiology and clinical significance of coinfection and distinguish primary varicella from VZV reactivation.
- 12 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Open AccessMpox and Varicella Zoster Virus coinfection in endemic and outbreak settings: a systematic review and meta-analysis
Background: MPOX-VZV co-infection poses diagnostic challenges and public health implications due to the overlap in clinical presentation and complications. Evidence on the epidemiology and clinical outcomes of MPOX-VZV co-infection remains limited. This systematic review and meta-analysis summarize the available epidemiological evidence and discusses the associated diagnostic and public health implications. Methods: A systematic and comprehensive literature search was performed in PubMed, Scopus, Web of Science, EMBASE, Google Scholar, and the Cochrane Library for studies published between January 2000 and October 2024, following PRISMA guidelines. We included studies that reported MPOX–VZV coinfection prevalence. Standard methods were used for data extraction and meta-analysis, and methodological quality was assessed using the Appraisal tool for Cross-Sectional Studies (AXIS). The pooled prevalence was derived from a random-effects meta-analysis; heterogeneity was evaluated with Cochran’s Q and I² statistics. Sensitivity analysis and tests for small-study effects were also performed (Egger’s regression, Begg’s test, and funnel plots). Subgroup analyses by region of residence and study period were also performed using the random-effects model. Results: Of the 860 records identified, 12 studies were eligible for inclusion, with data from the Democratic Republic of Congo, Nigeria, Brazil, Central African Republic, and Pakistan. The pooled prevalence across the included study populations was 21.3% (95% CI: 15.0–29.4%, Z = 5.93, P < 0.001). There was substantial heterogeneity (I²=93.6%), and event rates varied by region, study design, and diagnostic approach. The sensitivity analyses showed event rates ranging from 17.8% to 27.2% (I²=93.6%). Egger’s and Begg’s tests were non-significant; however, with only 12 studies, publication bias could not be excluded. Subgroup analyses showed comparable pooled prevalence between endemic and non-endemic settings and between the pre-2022 and 2022-outbreak periods, with neither region of residence nor study period reaching statistical significance as a moderator of prevalence (Q-between p = 0.907 and p = 0.132, respectively). Conclusions: In the included study populations, MPOX–VZV coinfection was observed in approximately one in five patients with mpox, but this estimate should be interpreted cautiously because of substantial heterogeneity and limited geographic coverage. Improved differential diagnostics, integrated surveillance, clinician awareness, and targeted public health interventions are recommended, particularly in endemic settings. Future research should clarify the epidemiology and clinical significance of coinfection and distinguish primary varicella from VZV reactivation.
- 5 April 2025
- Published by World Scientific Pub Co Pte Ltd in Nano LIFE
- Vol. 16 (03)
Synthesis and Characterization of pH-Responsive Sodium Alginate/Zein/γ-Alumina Nanocarriers for Targeted Curcumin Delivery in Lung Cancer
A feasible method to addressing some of the challenges that are associated with the treatment of lung cancer is the utilization of stimulus-responsive drug delivery systems that make use of the anticancer agent curcumin. As part of this research, pH-responsive nanocarriers were developed by employing sodium alginate (SA), zein and [ ]-alumina ([ ]-Al2O[ ] as curcumin nanocarriers. These nanocarriers were created by a W/O/W double emulsion technique. The purpose of this study was to facilitate the delivery of curcumin to lung cancer cells in a targeted manner. The FTIR and XRD techniques were utilized in order to characterize the crystalline structure and the physical interactions, respectively. DLS analysis and FE-SEM imaging, respectively, verified that the dimensions of drug-loaded nanocomposites measured 218.6 nm. These nanocomposites exhibited a monodisperse particle distribution and a rod-like shape according to the findings of the investigation. An ultraviolet-visible spectroscopy analysis was performed in order to investigate the pH sensitivity of the nanocarrier samples. The results obtained from the UV–Vis spectroscopy reveal that the absorption intensities are higher in the presence of acidic tumor settings (pH 5.4) in comparison to the physiological pH (7.4). In comparison to the previously recorded delivery systems, the double emulsion strategy, which utilized [ ]-alumina, demonstrated a significant improvement in terms of drug loading and entrapment efficiency. After that, MTT and flow cytometry tests were utilized in order to assess cytotoxicity and cellular death simultaneously. Based on the findings, it can be concluded that the SA/zein/ [ ]-Al2O3 nanocomposite has great potential as a pH-responsive drug delivery approach for the treatment of lung cancer.
- 5 April 2025
- Published by World Scientific Pub Co Pte Ltd in Nano LIFE
- Vol. 16 (03)
Synthesis and Characterization of pH-Responsive Sodium Alginate/Zein/γ-Alumina Nanocarriers for Targeted Curcumin Delivery in Lung Cancer
A feasible method to addressing some of the challenges that are associated with the treatment of lung cancer is the utilization of stimulus-responsive drug delivery systems that make use of the anticancer agent curcumin. As part of this research, pH-responsive nanocarriers were developed by employing sodium alginate (SA), zein and [ ]-alumina ([ ]-Al2O[ ] as curcumin nanocarriers. These nanocarriers were created by a W/O/W double emulsion technique. The purpose of this study was to facilitate the delivery of curcumin to lung cancer cells in a targeted manner. The FTIR and XRD techniques were utilized in order to characterize the crystalline structure and the physical interactions, respectively. DLS analysis and FE-SEM imaging, respectively, verified that the dimensions of drug-loaded nanocomposites measured 218.6 nm. These nanocomposites exhibited a monodisperse particle distribution and a rod-like shape according to the findings of the investigation. An ultraviolet-visible spectroscopy analysis was performed in order to investigate the pH sensitivity of the nanocarrier samples. The results obtained from the UV–Vis spectroscopy reveal that the absorption intensities are higher in the presence of acidic tumor settings (pH 5.4) in comparison to the physiological pH (7.4). In comparison to the previously recorded delivery systems, the double emulsion strategy, which utilized [ ]-alumina, demonstrated a significant improvement in terms of drug loading and entrapment efficiency. After that, MTT and flow cytometry tests were utilized in order to assess cytotoxicity and cellular death simultaneously. Based on the findings, it can be concluded that the SA/zein/ [ ]-Al2O3 nanocomposite has great potential as a pH-responsive drug delivery approach for the treatment of lung cancer.
- Open Access
- 22 October 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-12
Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis
One of the main risks of infection after hematopoietic stem cell transplantation (HSCT) is infection by gram-positive bacteria, including vancomycin-resistant enterococci (VRE). Based on the format of a global review and meta-analysis study, this study aims to investigate the incidence of VRE bloodstream infection (BSI) after HSCT in colonized individuals. The keywords of the systematic search included vancomycin-resistant enterococci and HSCT. These words were searched in Google Scholar, PubMed/Medline, Scopus, and Web of Science databases from January 1, 2000, to March 1, 2024. Studies that reported the prevalence of vancomycin-resistant enterococci in patients undergoing HSCT were included. The random effects model was used for the meta-analyses. Investigations were conducted according to PRISMA guidelines, and the protocol was registered in PROSPERO: CRD42024543491. Out of 1100 screened papers, 28 were eligible. The random effects model was established to analyze the incidence of VRE BSI after HSCT. The pooled prevalence of co-infection for Allo-HSCT recipients was 3.023 (95% CI, Z-value = -3.5, p-value < 0.0001), and this value for Auto-HSCT recipients was 11.89 (95% CI, Z-value = -2.923, p-value < 0.001). These results showed that the rate of BSI due to vancomycin-resistant enterococcus in Auto-HSCT recipients is higher than Allo-HSCT. The prevalence of vancomycin-resistant enterococci in Auto-HSCT recipients is higher than that of Allo-HSCT, possibly due to colonization of the intestines of these people with vancomycin-resistant enterococci before transplantation. VRE Colonization before transplantation increases the likelihood of post-transplant VRE BSI and other bacterial infections, including Gram-negative. The strains should be analyzed by sequencing before and after HSCT for a more detailed investigation.
- 22 October 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-12
Open AccessGlobal landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis
One of the main risks of infection after hematopoietic stem cell transplantation (HSCT) is infection by gram-positive bacteria, including vancomycin-resistant enterococci (VRE). Based on the format of a global review and meta-analysis study, this study aims to investigate the incidence of VRE bloodstream infection (BSI) after HSCT in colonized individuals. The keywords of the systematic search included vancomycin-resistant enterococci and HSCT. These words were searched in Google Scholar, PubMed/Medline, Scopus, and Web of Science databases from January 1, 2000, to March 1, 2024. Studies that reported the prevalence of vancomycin-resistant enterococci in patients undergoing HSCT were included. The random effects model was used for the meta-analyses. Investigations were conducted according to PRISMA guidelines, and the protocol was registered in PROSPERO: CRD42024543491. Out of 1100 screened papers, 28 were eligible. The random effects model was established to analyze the incidence of VRE BSI after HSCT. The pooled prevalence of co-infection for Allo-HSCT recipients was 3.023 (95% CI, Z-value = -3.5, p-value < 0.0001), and this value for Auto-HSCT recipients was 11.89 (95% CI, Z-value = -2.923, p-value < 0.001). These results showed that the rate of BSI due to vancomycin-resistant enterococcus in Auto-HSCT recipients is higher than Allo-HSCT. The prevalence of vancomycin-resistant enterococci in Auto-HSCT recipients is higher than that of Allo-HSCT, possibly due to colonization of the intestines of these people with vancomycin-resistant enterococci before transplantation. VRE Colonization before transplantation increases the likelihood of post-transplant VRE BSI and other bacterial infections, including Gram-negative. The strains should be analyzed by sequencing before and after HSCT for a more detailed investigation.
- Open Access
Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: a global systematic review and meta-analysis
Pseudomonas aeruginosa is one of the most common causes of diabetic foot infection globally. This study aimed to determine the global distribution of P. aeruginosa isolated from diabetic foot ulcer infection.
Open AccessEpidemiology of Pseudomonas aeruginosa in diabetic foot infections: a global systematic review and meta-analysis
Pseudomonas aeruginosa is one of the most common causes of diabetic foot infection globally. This study aimed to determine the global distribution of P. aeruginosa isolated from diabetic foot ulcer infection.
- 1 April 2017
- Vol. 20 (4) , 451-456
Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichia coli
This study aimed to investigate the effect of zinc oxide nanoparticles (ZnO-np) on biofilm formation and expression of the flu gene in uropathogenic Escherichia coli (UPEC) strains. Minimum inhibitory concentration (MIC) of ZnO-np was determined by agar dilution method. The effect of MIC and sub-MIC concentrations of ZnO-np on biofilm formation were determined by microtiter plate assay. The expression level of the flu gene was assessed by Real-Time PCR assay. MIC and sub-MIC ZnO-np concentrations reduced biofilm formation by 50% and 33.4%, respectively. Sub-MIC ZnO-np concentration significantly reduced the flu gene expression in the UPEC isolates (P<0.0001). The sub-MIC concentration of ZnO-np reduces biofilm formation and flu gene expression in UPEC isolates. It is suggested to use nanoparticles for coating medical devices to prevent bacterial colonization.
- 1 April 2017
- Vol. 20 (4) , 451-456
Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichia coli
This study aimed to investigate the effect of zinc oxide nanoparticles (ZnO-np) on biofilm formation and expression of the flu gene in uropathogenic Escherichia coli (UPEC) strains. Minimum inhibitory concentration (MIC) of ZnO-np was determined by agar dilution method. The effect of MIC and sub-MIC concentrations of ZnO-np on biofilm formation were determined by microtiter plate assay. The expression level of the flu gene was assessed by Real-Time PCR assay. MIC and sub-MIC ZnO-np concentrations reduced biofilm formation by 50% and 33.4%, respectively. Sub-MIC ZnO-np concentration significantly reduced the flu gene expression in the UPEC isolates (P<0.0001). The sub-MIC concentration of ZnO-np reduces biofilm formation and flu gene expression in UPEC isolates. It is suggested to use nanoparticles for coating medical devices to prevent bacterial colonization.